Endometrial Cancer Everest Medicines Announces Approval of Trodelvy® in China for Second-Line Metastatic Triple-Negative Breast CancerBy adminJune 10, 20220 Trodelvy is Everest’s First Product to Receive Regulatory Approval in China Everest Plans to Launch Commercial Sales of Trodelvy…
